Cargando…

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

BACKGROUND: Breast cancer is a heterogeneous disease displaying distinct molecular features and clinical outcome. The molecular profile of triple-negative breast cancers (TNBCs) overlaps with that of basal-like breast cancers that in turn show similarities with high-grade serous ovarian and endometr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doberstein, Kai, Milde-Langosch, Karin, Bretz, Niko P, Schirmer, Uwe, Harari, Ayelet, Witzel, Isabell, Ben-Arie, Alon, Hubalek, Michael, Müller-Holzner, Elisabeth, Reinold, Susanne, Zeimet, Alain G, Altevogt, Peter, Fogel, Mina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301892/ https://www.ncbi.nlm.nih.gov/pubmed/25510351 http://dx.doi.org/10.1186/1471-2407-14-958

Ejemplares similares

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
por: Schirmer, Uwe, et al.
Publicado: (2014)

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
por: Doberstein, Kai, et al.
Publicado: (2022)

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
por: Notaro, Sara, et al.
Publicado: (2016)

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions
por: Pfeifer, Marco, et al.
Publicado: (2010)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
por: Legler, Karen, et al.
Publicado: (2018)

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer
por: Tischler, Verena, et al.
Publicado: (2011)

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
por: Salnikov, A V, et al.
Publicado: (2013)

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
por: Seeber, Andreas, et al.
Publicado: (2015)

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
por: Ihnen, M., et al.
Publicado: (2010)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016)

Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults
por: Harari, Ayelet, et al.
Publicado: (2020)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity
por: Riedle, Svenja, et al.
Publicado: (2009)

Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status
por: Milde-Langosch, K, et al.
Publicado: (2001)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
por: Ihnen, M, et al.
Publicado: (2010)

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

Effects of aromatizable and nonaromatizable androgens on the sex inversion of red-spotted grouper (Epinephelus akaara)
por: Li, Guang-Li, et al.
Publicado: (2006)

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
por: Hille, Claudia, et al.
Publicado: (2019)

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2011)

CAM Models: Lessons and Implications for CAM Evolution
por: Burgos, Asdrubal, et al.
Publicado: (2022)

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
por: Mechtersheimer, Sabine, et al.
Publicado: (2001)

TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
por: Mahner, Sven, et al.
Publicado: (2010)

Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial
por: Witzel, Isabell, et al.
Publicado: (2019)

Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates
por: Ivell, Richard, et al.
Publicado: (2003)

Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes
por: Yasui, Saya, et al.
Publicado: (2023)

Spatio-temporal dynamics and laterality effects of face inversion, feature presence and configuration, and face outline
por: Marinkovic, Ksenija, et al.
Publicado: (2014)

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
por: Deng, Qingfu, et al.
Publicado: (2019)

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
por: Deng, Qingfu, et al.
Publicado: (2022)

CAM in Psychiatry
por: Melzer, Jörg, et al.
Publicado: (2013)

eCAM benefits from diversity that derives from CAM
por: Cooper, Edwin L.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_oqkrs5b545m7gdj6uooi547moj